Korea
THE LOVELY DESTROYER - NEW HERO LETTY LIGHTS UP THE BATTLEFIELD IN THE LATEST VINDICTUS UPDATE
SEOUL, South Korea, March 22, 2022 /PRNewswire/ -- Heavy cannon gunner, Letty,
is now open to play in Nexon's popular MMORPG
3billion to reveal its diagnostic performance at ACMG annual meeting 2022
SEOUL, South Korea, March 21, 2022 /PRNewswire/ -- 3billion announced that Chief Medical Officer Dr.Go Hun Seo will introduce a research poster at ACMG annual meeting 2022, held inNashville, TN, from March 22 through 26. This poster highlights the importance of continuous reanalysis for undiagnos...
RNAGENE Signs a Collaborative Research Agreement with PharmAbcine to Develop Novel mRNA Therapeutics
SEOUL, South Korea, March 21, 2022 /PRNewswire/ -- RNAGene Inc., a South Korean biotech which specializes in the development of mRNA (messenger ribonucleic acid)-based therapeutics, announced today that it has signed a Collaborative Research Agreement with PharmAbcine Inc. (KOSDAQ: 208340ks), a c...
MODAMODA Shampoo selling 7 bottles per minute at Amazon, now opens its own brand mall in the US
SEOUL, South Korea, March 18, 2022 /PRNewswire/ -- MODAMODA, a bio-cosmetics
company (PresidentAyden Bae) announced the official launch of its online brand
mall (www.trymodamoda.com
Seegene appoints Dr. Glen Hansen as Head of Medical Affairs of U.S. subsidiary
SEOUL, South Korea, March 17, 2022 /PRNewswire/ -- Seegene Inc.
Chang Il-Moo, a former head of R&D department at KGC, wins James A. Duke award from the American Botanical Council
SEOUL, South Korea and ANAHEIM, Calif., March 16, 2022 /PRNewswire/ -- Chang Il-Moo, who successively served as the head of R&D department at the Korea Ginseng Corporation (KGC, CEOKim Jae-Su), won the 2021 Duke Award, the top writing award granted by the American Botanical Council (ABC), forA Hi...
ROKIT Healthcare's Latest Paper About Its AI Technology Has Been Accepted to CVPR 2022
SEOUL, South Korea, March 15, 2022 /PRNewswire/ -- ROKIT Healthcare, a global hyper-personalized organ regeneration company, announced onMarch 7th that its paper about the "AI and 3D bioprinting convergence technology for regenerative treatments" has been accepted to 2022 IEEE/CVF Conference on C...
NuclixBio Announces a Collaborative Research Agreement with PharmAbcine
SEOUL, South Korea, March 14, 2022 /PRNewswire/ -- NuclixBio Inc., a South Korean biotech company that focuses on research and development of mRNA therapeutics, announced today that it has signed a Collaborative Research Agreement with PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech...
Beyond Music, the Korean version of Hipgnosis, to conquer the global music IP market by taking over a large-scale music catalog management company
* Beyond Music is the largest management company for music intellectual properties (IPs) in S. Korea * They have taken over 'FNC Investment', the second largest music IP management company in S. Korea, and made a strategic partnership with Dreamus Company, a subsidiary of SK Square * They h...
Dot Inc. Announces the World's First Tactile Braille Display, Compatible with iPhone and iPad
* New Dot Pad display from Dot Inc. helps blind/low-vision users feel tactile images in real-time * It will be showcased at the CSUN's Assistive Technology Conference in March 2022 * Dot Pad is now available to developer communities and early adopters on Dot's official website SEOUL, South ...
Ascenda partners with Hyundai Card to support launch of new cards in South Korea
SEOUL, South Korea, March 10, 2022 /PRNewswire/ -- Ascenda, the technology company that makes payments and banking more rewarding, has partnered with Hyundai Card, a leading credit card issuer, to power the launch of a new lineup of consumer and corporate cards on the American Express Network inS...
Bridge Biotherapeutics to Present Preclinical Data of BBT-207 at the AACR 2022 Annual Meeting
* The abstract of BBT-207 pre-clinical studies is now available at the AACR website * Preclinical data suggests that BBT-207 may have the potential to be positioned as a frontline treatment with the anti-tumor effects in EGFR mutant NSCLC SEONGNAM, South Korea, March 9, 2022 /PRNewswire/ -- B...
Hankyung.com's introduces: Cost effective K-beauty products, SMEs whose exports jumped 125% in two years
SEOUL, South Korea, March 9, 2022 /PRNewswire/ -- Following announcement covered by Hankyung.com, Certain Korean companies actively export Korean cosmetics to global K-beauty market. Founded in 2013, Goshen Korea is a small and medium-sized company with a capital of100 million won and 17 employee...
Woongjin ThinkBig Globally Launches AI Math Tutor App 'Mathpid'
SEOUL, South Korea, March 8, 2022 /PRNewswire/ -- Woongjin ThinkBig Co., Ltd,
South Korea's leading edtech company, launches AI-based arithmetic application
'Mathpid' in the global market, including the U.S.,Canada, and Singapore.
Bridge Biotherapeutics Enters into an Option-to-License Agreement with CellionBioMed to Develop BBT-301 for the Treatment of Multiple Fibrotic Diseases
* The company reinforces its strategic focus on fibrotic diseases including idiopathic pulmonary fibrosis (IPF) * Through the option-to-license agreement, Bridge will develop a novel anti-fibrotic ion channel modulator, which is a preclinical candidate SEONGNAM, South Korea, March 7, 2022 /PR...
Hankyung.com introduces: When thinking of pleated clothes, think of Korea, not Japan. What "Pleatsme" wants for the future
SEOUL, South Korea, March 7, 2022 /PRNewswire/ -- Following announcement covered by Hankyung.com, Pleated clothes used to be exclusive for the 50s to 60s but are now captivating young people in their 20s and 30s with practicality and convenience. The uniqueness of the material is also why Gen Z...
RAON with BTS: A BTS themed Korean language board game released in the U.S.
PAJU, South Korea, March 4, 2022 /PRNewswire/ -- RAON with BTS distributed by Korea Boardgames is now available in the U.S. and can be purchased through Amazon. The game features Korean and English rules to help consumers from around the world to easily learn and play with the Korean language. ...
Genome and Company announces Clinical Trial Collaboration with MSD to evaluate 'GEN-001' in combination of KEYTRUDA® (pembrolizumab) in phase 2 clinical trial in biliary tract cancer patients
SEOUL, South Korea, March 3, 2022 /PRNewswire/ -- Genome and Company (KOSDAQ: 314130, CEO∙CTO: Jisoo Pae∙Hansoo Park), a leading global microbiome anti-cancer drug development company, announced it has entered into a first Clinical Trial Collaboration and Supply Agreement (CTCSA) with MSD (a trad...
Hanwha Solutions supplies Samsung Electronics with recycled ocean-bound materials for Galaxy devices
* The Company's wholly-owned subsidiary Hanwha Compound produces eco-conscious materials using discarded fishing nets. * Use of recycled ocean-bound materials across Samsung's mobile devices will help improvemarine biodiversity and fulfill ESG mandate. * "Expanding them into automotive elect...
Hankyung.com's introduces: Hanteo Global got attention at the CES with their K-pop Business Model
SEOUL, South Korea, March 3, 2022 /PRNewswire/ -- Following announcement covered by Hankyung.com, Hanteo Global is a company that attracts attention with its differentiated services by combining K-pop and data technology. They are a startup company using artificial intelligence for big data in mu...
Week's Top Stories
Most Reposted
Troy Animal Healthcare Strengthens Quality Operations with Veeva Vault Quality
[Picked up by 321 media titles]
2024-05-17 07:00Ultima Markets Recognised as Most Popular Broker 2024 by BrokersView
[Picked up by 319 media titles]
2024-05-15 12:00Home to half of the world's top 10 trending tourism destinations, Asia Pacific is making a comeback: Mastercard Economics Institute on travel in 2024
[Picked up by 303 media titles]
2024-05-16 15:00US-BASED PANDUIT ELEVATES MANUFACTURING LANDSCAPE WITH NEW STATE-OF-THE-ART PLANT IN JOHOR BAHRU, MALAYSIA
[Picked up by 274 media titles]
2024-05-16 09:39Trip.com Group and Rezdy Join Forces to Offer New Travel Experiences Around the World
[Picked up by 229 media titles]
2024-05-14 18:07